Impact of Adding Instrument-assisted Soft Tissue Mobilization to Mulligan Therapy in Patients With Cervicogenic Headache
CGH
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
this study will be conducted to investigate the impact of adding Instrument assisted soft tissue mobilization technique to mulligan therapy in patients with cervicogenic headache
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
January 28, 2026
January 1, 2026
5 months
January 21, 2026
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
neck disability
Assessment of neck function was performed by Arabic neck disability index. It is a valid and reliable tool in the assessment of neck function. It contains ten category/classes. Each category contains six choices (zero-five).Score from zero to four no disability, from five to 15 this is mild, From 15 to 24 this is moderate, from 25 to 34 this is severe, more than 34 this is a complete disability
up to 6 weeks
Secondary Outcomes (6)
pain intensity
up to 6 weeks
cervical range of motion
up to six weeks
muscle stiffness
up to six weeks
headache frequency
up to six weeks
headache duration
up to six weeks
- +1 more secondary outcomes
Study Arms (3)
instrumeted assissted soft tissue mobilization and mulligan therapy
EXPERIMENTALtwenty patients will receive IASTM, mulligan therapy and postural correction exercises three times per week for 6 weeks.
mulligan therapy
EXPERIMENTALTwenty patients will receive Mulligan therapy and postural correction exercises three times per week for 6 weeks.
postural correction exercises
ACTIVE COMPARATORTwenty patients will receive postural correction exercises three times per week for 6 weeks.
Interventions
the exercises will incluse, Stretching exercises for the sternocleidomastoids,the Scalenes,upper fibers of trapezius and strengthening exercises for cervical muscles
the patients will receive IASTM tools over the length of targeted muscles (descending fiber of trapezius, suboccipitalis muscles ) for 5 minutes. also, SNAG technique; Each patient will be asked to sit comfortably, and the treating therapist will stand beside the patient. The patient's head will be free and cradled between the therapist's right forearm and body, and the therapist stand at the patient's right side. The therapist then will place his right index, middle, and ring fingers at the base of the occiput and kept his right little finger over the spinous process of C2. Next, with the lateral border of his left thenar eminence, gentle pressure will be applied in a ventral and upward direction(45 degrees) over the right little finger. finally postural correction execises
SNAG technique; Each patient will be asked to sit comfortably, and the treating therapist will stand beside the patient. The patient's head will be free and cradled between the therapist's right forearm and body, and the therapist stand at the patient's right side. The therapist then will place his right index, middle, and ring fingers at the base of the occiput and kept his right little finger over the spinous process of C2. Next, with the lateral border of his left thenar eminence, gentle pressure will be applied in a ventral and upward direction(45 degrees) over the right little finger. Finally, postural correction exercises will be addedd
Eligibility Criteria
You may qualify if:
- Unilateral CGH presentation
- Age group above 18 years' old
- History of chronic CGH (\>3 months)
- CGH owing to cervical spine (neck) dysfunction
- Reduced cervical motion
- Neck stiffness and movement restriction
You may not qualify if:
- Participants with other types of headache (migraine headache)
- Headache owing to other causes (sinus, tumor, neural, and tempero-mandibular joint issues)
- Any contraindications to manual and manipulative therapy (fracture, instability, osteoporosis and neural symptoms)
- Taking analgesics or corticosteroids and migraine-specific medications, such as triptans
- Metastasis
- Cardiac conditions (stroke and syncope)
- Neurological conditions (radiculopathy, myelopathy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- opaque sealed envelope
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator : doaa youssef ahmed mahmoud
Study Record Dates
First Submitted
January 21, 2026
First Posted
January 28, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
January 28, 2026
Record last verified: 2026-01